| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |